Previous Article | Next Article ![]()
Journal of Virology, June 1999, p. 4794-4805, Vol. 73, No. 6
Laboratory of Molecular Genetics, National
Institute of Child Health and Human Development, Bethesda, Maryland
20892,1 and AIDS Vaccine Program,
SAIC-Frederick, NCI-Frederick Cancer Research and Development Center,
Frederick, Maryland 217022
Received 29 December 1998/Accepted 9 March 1999
We have developed a reconstituted system which models the events
associated with human immunodeficiency virus type 1 (HIV-1) plus-strand
transfer. These events include synthesis of plus-strand strong-stop DNA
[(+) SSDNA] from a minus-strand DNA donor template covalently
attached to human tRNA3Lys, tRNA primer removal, and
annealing of (+) SSDNA to the minus-strand DNA acceptor template.
Termination of (+) SSDNA synthesis at the methyl A (nucleotide 58) near
the 3' end of tRNA3Lys reconstitutes the 18-nucleotide
primer binding site (PBS). Analysis of (+) SSDNA synthesis in vitro and
in HIV-1 endogenous reactions indicated another major termination site:
the pseudouridine at nucleotide 55. In certain HIV-1 strains,
complementarity between nucleotides 56 to 58 and the first three bases
downstream of the PBS could allow all of the (+) SSDNA products to be
productively transferred. Undermodification of the tRNA may be
responsible for termination beyond the methyl A. In studies of tRNA
removal, we find that initial cleavage of the 3' rA by RNase H is not
sufficient to achieve successful strand transfer. The RNA-DNA hybrid
formed by the penultimate 17 bases of tRNA still annealed to (+) SSDNA must also be destabilized. This can occur by removal of additional 3'-terminal bases by RNase H (added either in cis or
trans). Alternatively, the nucleic acid chaperone activity
of nucleocapsid protein (NC) can catalyze this destabilization. NC
stimulates annealing of the complementary PBS sequences in (+) SSDNA
and the acceptor DNA template. Reverse transcriptase also promotes
annealing but to a lesser extent than NC.
During retrovirus replication, a
linear, double-stranded DNA copy of the viral RNA genome is synthesized
in a complex series of steps catalyzed by the virus-encoded enzyme
reverse transcriptase (RT) (25; for reviews, see
references 3 and 12). Two strand transfer reactions, minus- and plus-strand DNA transfer, are required for elongation of each strand and for synthesis of the long terminal repeat present at the ends of proviral DNA (reviewed in reference 68).
Reverse transcription is initiated by a cellular tRNA primer which is
bound to the primer binding site (PBS) located near the 5' end of viral
RNA (12). The first product formed, a short DNA termed
minus-strand strong-stop DNA [( In addition to work demonstrating the important role of RNase H, many
studies have shown that human immunodeficiency virus type 1 (HIV-1)
nucleocapsid protein (NC) dramatically stimulates HIV-1 minus-strand
transfer (2, 15, 27, 41, 53, 60, 75). NC is able to exert
this effect because it exhibits nucleic acid chaperone activity
(32, 59), i.e., it is able to catalyze conformational
rearrangements of nucleic acids which result in more thermodynamically
stable structures having the maximal number of base pairs (6,
16, 17, 27, 33, 37, 40, 46, 51, 69, 73, 75; also see
reference 13 and references therein). Thus, during
HIV-1 minus-strand transfer, NC transiently destabilizes the
complementary TAR structures at the 3' ends of ( Interestingly, the strategy RT uses to make plus-strand DNA has many
similarities to the strategy employed for synthesis of minus-strand
DNA. For example, RT also initiates plus-strand DNA synthesis with an
RNA primer, in this case, a purine-rich sequence known as the
polypurine tract (PPT) (for references before 1993, see reference
10; also see references 21, 56,
and 58). Plus-strand priming occurs while
minus-strand DNA is being elongated; the template is minus-strand DNA
which has the tRNA primer (for HIV-1, tRNA3Lys) still
attached to its 5' end. The initial product is a short DNA termed
plus-strand SSDNA [(+) SSDNA]. Synthesis of (+) SSDNA continues until
the 18 nucleotides (nt) at the 3' end of the tRNA are copied, which
reconstitutes the PBS.
Since the 19th base from the 3' end of all retroviral tRNA primers is a
methyl A (reviewed in reference 49) and RT-catalyzed elongation is blocked at modified bases (see the review by Marquet [49] and references therein), current models for
reverse transcription specify that synthesis of (+) SSDNA terminates
when RT encounters the first modified base in the tRNA (25).
For example, the murine leukemia virus (MuLV) (+) SSDNA intermediate
generated in vivo stops precisely after RT has copied the first 18 nt
at the 3' end of tRNAPro (61). It was also
reported that the methyl A (nt 58) of tRNA3Lys is the
major termination site for synthesis of HIV-1 (+) SSDNA synthesis in
vitro (8). However, another study with an HIV-1 reconstituted system showed that (+) SSDNA synthesis is not terminated exclusively at the methyl A position (4). If
tRNA3Lys is completely unmodified, the entire molecule
is reverse transcribed and plus-strand transfer will not take place
(4, 8, 76).
Before the actual plus-strand transfer event can occur, RNase H
cleavage is again required. Here, the tRNA must be removed to allow (+)
SSDNA to anneal to the 3' end of minus-strand DNA, a step mediated by
base pairing of the 18-nt complementary PBS sequences. Analysis of the
sequences at HIV-1 circle junctions (34, 43, 65, 70) and
characterization of in vitro HIV-1 RNase H reactions (23, 57,
66) indicate that the initial cleavage is not at the RNA-DNA
junction but instead occurs between the 3'-terminal rA and penultimate
rC in tRNA3Lys, leaving the rA at the 5' end of ( In the studies of HIV-1 RNase H activity, in vitro secondary cleavage
of an 18-nt RNA oligonucleotide representing the 3'-terminal sequences
of tRNA3Lys was observed (11, 66). However,
the question of whether this event is obligatory for complete removal
of the primer was not addressed. In addition, a direct role for NC in
HIV-1 plus-strand transfer has not been demonstrated; in one study, it
was reported that mutations in the N-terminal zinc finger of HIV-1 NC
did not affect plus-strand transfer in vivo (67).
In this work, we have investigated three aspects of plus-strand
transfer: (i) termination of (+) SSDNA synthesis, (ii) tRNA primer
removal, and (iii) a possible role for NC. To clarify these issues, we
have developed a reconstituted system which models the events
associated with plus-strand transfer and includes the use of a donor
DNA template that contains human tRNA3Lys. Analysis of
(+) SSDNA synthesis in this system and in endogenous RT assays with
detergent-treated HIV-1 virions clearly demonstrates that position 58 in the tRNA3Lys primer is not an exclusive termination
site: there are additional (+) SSDNA products which terminate at or
near two other modified bases in the tRNA. Moreover, we find that in
certain HIV-1 strains, products terminated before the second modified
base (a pseudouridine [ Materials.
Purified tRNA3Lys from human
placenta was obtained from Bio S&T (Lachine, Quebec, Canada). DNA
oligonucleotides were purchased from Lofstrand (Gaithersburg, Md.) or
from Oligo's Etc., Inc. (Wilsonville, Oreg.). RNA and chimeric DNA-RNA
oligonucleotides were obtained from Oligo's Etc., Inc. An RNase
H-minus HIV-1 RT having a point mutation changing residue E478 to Q
(62) was a gift from Stuart Le Grice (HIV Drug Resistance
Program, NCI-Frederick Cancer Research and Development Center,
Frederick, Md.). Escherichia coli RNase H was kindly
supplied by Robert Crouch (National Institute of Child Health and Human
Development, National Institutes of Health, Bethesda, Md.). The sources
of all other materials are given in Guo et al. (27).
Preparation of the minus-strand DNA donor template containing
tRNA3Lys.
A threefold excess of a 50-nt
plus-strand DNA oligonucleotide template (JL278), representing (+)
SSDNA and having the sequence 5'-CCC TTT TAG TCA GTG TGG AAA ATC TCT
AGC AGT GGC GCC CGA ACA GGG AC-3', nt 604 to 653 in NL4.3
(1), was annealed to tRNA3Lys. The annealing
was carried out at 65°C for 5 min in buffer consisting of 50 mM
Tris-HCl (pH 8.0) and 75 mM KCl; the mixture was then gradually cooled
to 37°C for about 30 min. A 32-nt minus-strand donor DNA
[corresponding to the 5'-terminal sequences of ( RT assays. (i) In vitro strand transfer assay.
The assay was
performed with either of two chimeric DNA-RNA donor templates: (i) a
32-nt minus-strand DNA oligonucleotide representing ( (ii) RNase H cleavage assay.
Reactions were performed under
the conditions of the in vitro strand transfer assay (see above),
except that the donor templates containing either
tRNA3Lys (see above) or the 18-nt RNA sequence (3' end
of tRNA3Lys) were labeled with 32P at their
5' ends (29); the specific activities for the two donors
were ~4.8 × 103 cpm/0.2 pmol and ~6.5 × 105 cpm/0.2 pmol, respectively. The 20-nt DNA primer was
unlabeled. RNA cleavage products produced from the
tRNA3Lys-containing donor or from the 18-nt
RNA-containing donor were resolved by electrophoresis in a 6 or 12.5%
sequencing gel, respectively, and were quantified as described above.
(iii) Assay for secondary RNase H cleavage during plus-strand
transfer.
For this assay, we used oligonucleotides representing
the intermediates which are present after the initial RNase H cleavage at the 3' end of tRNA3Lys: (i) the 32-nt minus-strand
DNA donor template with an rA attached at its 5' end (JL354; 5'-rA CTG
CTA GAG ATT TTC CAC ACT GAC TAA AAG GG, complementary to nt 604 to 636 in NL4.3 [1], (ii) a 17-nt RNA oligonucleotide
representing the 17 remaining bases at the 3' end of
tRNA3Lys (JL353; 5'-GUC CCU GUU CGG GCG CC-3',
complementary to nt 637 to 653 in NL4.3 [1]), and
(iii) a 50-nt oligonucleotide (JL278) representing (+) SSDNA (see
above). For the experiments in which RNase H cleavage was measured
directly, the 17-nt RNA was labeled at its 5' end with 32P
(29). In experiments in which synthesis of the 80-nt strand transfer product was measured, a fivefold excess of the chimeric 33-nt
DNA-RNA oligonucleotide and the 17-nt RNA oligonucleotide (each at 1 pmol) were annealed to (+) SSDNA (0.2 pmol) labeled at its 5' end with
32P (5.8 × 106 cpm/0.2 pmol), as
described previously (27). In all cases, reactions were
continued following addition of the acceptor DNA template,
MgCl2, dNTPs, and RT, as indicated above (section i), except that the enzymes added were either wild-type HIV-1 RT, RNase
H-minus HIV-1 RT (62), or RNase H-minus HIV-1 RT plus E. coli RNase H (each at 0.2 pmol). Incubation was for
1 h at 37°C. Where specified, NC was added following annealing
of the chimeric DNA-RNA oligonucleotide and 17-nt RNA to
32P-labeled (+) SSDNA; in these experiments, reaction
mixtures contained either wild-type RT or RNase H-minus RT
(62). Note that the DNA primer was not present in this assay.
Southern blot hybridization.
The procedures used for
Southern blot analysis were performed essentially as described by
Miller et al. (50). Briefly, a HindIII digest
of DNA synthesized in a 6-h endogenous RT reaction with four unlabeled
dNTPs (27) was subjected to electrophoresis in a 6%
sequencing gel. The gel was transferred by electroblotting to a
Hybond-N+ filter (Amersham Life Sciences, Inc.). The filter was rinsed
one time with 10× SSC (1× SSC is 0.15 M NaCl and 0.015 sodium
citrate), cross-linked as described by Miller et al. (50), and then air dried. Prehybridization was carried out at 65°C for 4 h in 25 to 30 ml of buffer (Quality Biological, Inc.,
Gaithersburg, Md.) containing 6× SSC, 5× Denhardt's solution, and
0.5% sodium dodecyl sulfate (SDS); herring sperm DNA (Sigma), at a
final concentration of 100 µg/ml, was also present. Hybridization to
a 32P-labeled DNA oligonucleotide probe (total of 2 × 108 cpm) which detects sequences at the 3' end of (+) SSDNA
was performed by further incubation at 65°C overnight. The filter was
washed twice for 20 min at 60°C with 2× SSC and 0.1% SDS and for 20 min at 60°C with 0.5× SSC and 0.1% SDS; it was then air dried and exposed to Kodak XAR-5 film. A sequencing ladder was generated with the
M13 template supplied in a Sequenase kit (U.S. Biochemical Corp.).
Recombinant HIV-1 NC.
Methods for cloning, expression, and
purification of recombinant HIV-1 NC having 55 amino acid residues are
described by Wu et al. (73).
Reconstituted plus-strand transfer system.
To investigate the
mechanism of plus-strand transfer, we designed a model system which
mimics events which occur at this stage in reverse transcription. As
shown in Fig. 1, reaction 1, synthesis of
(+) SSDNA, is carried out with a donor template containing a 32-nt
minus-strand DNA oligonucleotide [representing the 5'-terminal sequences of (
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Molecular Requirements for Human Immunodeficiency
Virus Type 1 Plus-Strand Transfer: Analysis in Reconstituted and
Endogenous Reverse Transcription Systems
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) SSDNA], is translocated to the 3'
end of the genome (either by intra- or intermolecular strand transfer)
in a reaction facilitated by base pairing of the repeat (R) region at
the 3' terminus of viral RNA and its complement in (
) SSDNA (reviewed
in reference 68). RNase H degradation of the viral
genome (10), including removal of the 5'-terminal 14 to 18 bases by the polymerase-independent mode of RNase H cleavage (22,
26, 55) (what we have previously termed 3'-OH-independent RNase H
activity [55]), frees (
) SSDNA for the annealing
reaction (5, 11, 18, 24, 54).
) SSDNA and viral
RNA, thereby preventing self-priming reactions (27, 45, 47)
and promoting annealing (28, 44, 46, 75).
)
SSDNA. Recently, similar observations have been reported for the
initial cleavage of the MuLV primer, tRNAPro, during MuLV
plus-strand synthesis; in this case, the rA is ultimately removed from
the 5' end of minus-strand DNA (63, 64).
]) at the 3' end of the tRNA
(48) may be productively transferred. We also show that
initial cleavage of rA from the tRNA is not sufficient for successful
strand transfer. The RNA-DNA hybrid formed by the penultimate 17 tRNA
bases still annealed to (+) SSDNA has a high melting temperature
(Tm) and must therefore be destabilized to allow
complete removal of the tRNA primer. This can be accomplished by RNase
H-catalyzed secondary cleavage to remove additional bases from the 3'
end of the tRNA or by the nucleic acid chaperone activity of NC.
Finally, as is the case for minus-strand transfer (14, 28, 44, 46,
75), we demonstrate that HIV-1 NC stimulates the annealing
reaction in plus-strand transfer.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) SSDNA] was
synthesized with T4 DNA polymerase (Boehringer Mannheim), with
tRNA3Lys as the primer and the 32-nt unannealed portion
of the 50-nt (+) SSDNA as the template. Following termination of the
reaction, unextended tRNA3Lys (76 nt), unreacted 50-nt
(+) SSDNA, and tRNA3Lys covalently attached to the DNA
donor (108 nt) were separated by electrophoresis in a 6% sequencing
gel. The 108-nt product was eluted from the gel, further purified with
a GENECLEAN II kit (BIO 101), and stored at
80°C. For RNase H
cleavage assays, the tRNA3Lys donor template was
dephosphorylated with calf intestinal phosphatase (1 U/µg of
tRNA3Lys; Boehringer Mannheim) at 50°C for 2 h,
extracted several times with phenol-chloroform, precipitated with
alcohol, and then labeled with 32P at its 5' end, as
described previously (29). Due to steric hindrance, the 5'
phosphorylation of tRNA3Lys was less efficient than the
corresponding reaction with oligonucleotides.
) SSDNA,
covalently attached to tRNA3Lys (see above) and having
the sequence 5'-CTG CTA GAG ATT TTC CAC ACT GAC TAA AAG GG-3',
complementary to nt 604 to 635 (1), and (ii) a synthetic
50-nt chimeric DNA-RNA oligonucleotide (JL237) containing the same
32-nt DNA sequence covalently attached to RNA consisting of the first
18 bases at the 3' end of tRNA3Lys (5'-GUC CCU GUU CGG
GCG CCA-3', complementary to the PBS, nt 636 to 653 in NL4.3
[1]). DNA synthesis was initiated with a 20-nt DNA
primer (JL239), 5'-CCC TTT TAG TCA GTG TGG AA-3', nt 604 to 623 in
NL4.3 (1), labeled at its 5' end with 32P, as
described previously (29). The donor DNA (0.2 pmol) was annealed to the 5'-end-labeled DNA primer (0.4 pmol, ~2 × 106 cpm) at 65°C for 5 min, followed by slow cooling to
37°C for ~30 min, as described by Guo et al. (27). A
detailed description of the procedures used in the assay is given by
Guo et al. (27), except that in the present work, the
acceptor template (0.2 pmol) is a 48-nt minus-strand DNA (JL238):
5'-GAT CTC CTC TGG CTT TAC TTT CGC TTT CAA GTC CCT GTT CGG GCG CCA-3',
complementary to nt 636 to 683 in NL4.3 (1). The final
concentration of the 20-nt DNA primer was 20 nM; the donor and acceptor
templates as well as RT were present at final concentrations of 10 nM.
Reactions (final volume, 20 µl) were initiated by addition of
MgCl2 and the four deoxynucleoside triphosphates (dNTPs)
and, unless specified otherwise, were incubated for 60 min at 37°C.
Termination of reactions and electrophoresis of the DNA products in 6%
sequencing gels were performed as previously described (27).
Radioactive DNA products were quantified by using a PhosphorImager
(Molecular Dynamics) and ImageQuant software; calculations were
performed as indicated in reference 27.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) SSDNA] covalently attached to the 76-nt natural tRNA3Lys primer. A 32P-labeled 20-nt DNA
oligonucleotide (rather than the PPT in genomic RNA) serves as the
primer for (+) SSDNA synthesis in these experiments. After copying 12 nt of DNA, RT copies the 18-nt sequence at the 3' end of the tRNA and
thereby reconstitutes the PBS. In the next step (reaction 2), the tRNA
primer is removed by RNase H cleavage. The actual transfer event
(reaction 3) occurs when the 18-nt PBS sequence in (+) SSDNA and its
complement in the 48-nt minus-strand DNA acceptor template are
annealed. As the acceptor strand is elongated, RT also catalyzes strand
displacement of the donor DNA template. (Strand displacement has been
extensively studied by others [7, 20, 35, 36, 71, 72]
and is not directly examined here.) In this system, elongation
(reaction 4) of the plus- and minus-DNA strands yields an 80-nt,
linear, double-stranded DNA product.

View larger version (20K):
[in a new window]
FIG. 1.
Schematic diagram illustrating the HIV-1 model system
for plus-strand transfer. (Reaction 1) Synthesis of (+) SSDNA.
Plus-strand DNA synthesis is initiated with a 32P-labeled
20-nt DNA primer; the label is indicated by an asterisk. Experiments
were carried out with a donor template containing a 32-nt minus-strand
DNA [representing the 32 nt at the 5' end of (
) SSDNA] attached to
tRNA3Lys (template size, 108 nt). During DNA synthesis,
RT first copies 12 nt of DNA and then copies the 18-nt sequence from
the 3' end of tRNA3Lys, thereby reconstituting the PBS.
(Reaction 2) tRNA primer removal. In this step, RNase H cleavage occurs
at the 3' end of tRNA3Lys. (Reaction 3) Annealing and
strand displacement. (+) SSDNA containing the reconstituted PBS is
annealed to the complementary PBS sequence (pbs) in the minus-strand
acceptor DNA (48 nt). As the acceptor strand is elongated, there is
also displacement of the DNA moiety of the donor template. (Reaction 4)
Elongation of plus- and minus-strand DNA chains. The final product is
an 80-nt linear, double-stranded DNA. Filled arrow, plus-strand DNA;
open arrow, minus-strand DNA. The tRNA structure is depicted
schematically and the first modified base (a methyl A) is shown. The
figure is not drawn to scale. mA, methyl A.
Synthesis of plus-strand DNA with the tRNA3Lys
donor template.
The time course of plus-strand DNA synthesis
(reaction 1 in Fig. 1) was investigated with a donor DNA template
having the 5'-terminal sequences of (
) SSDNA covalently attached to
the tRNA3Lys primer and the DNA primer labeled with
32P (Fig. 2). Under the
conditions of the assay, (+) SSDNA was synthesized to a significant
extent within the first 5 min of incubation (lane 1) whereas the
plus-strand transfer product [(+) 80 nt] was not detected before 10 min (lane 2). This lag in synthesis of the (+) 80 nt DNA is reminiscent
of the 5- to 10-min delay between the detection of (
) SSDNA and the
appearance of the minus-strand DNA transfer product, which we observed
previously in an HIV-1 reconstituted minus-strand transfer system
(27). Note that there was no synthesis of the (+) 80-nt DNA
when the acceptor DNA template was omitted from the reaction (Fig. 2,
lane C).
|
at position 55 and another termination site at a second
at
position 39. This possibility would result in synthesis of 53- and
69-nt products, respectively. Figure 3B illustrates the 3'-terminal
bases expected to be present in each of the 51- to 53-nt products. For
many of the HIV-1 strains in a class designated "consensus B"
(42), including NL4.3 (1) and MN (30),
both of which we have used in this study, each of the three additional
bases (5'-TTG) in the 53-nt (+) SSDNA is also immediately downstream of
the PBS in the viral genome. Thus, in our system, when RT copies the
3'-AAC sequence in tRNA3Lys (positions 58 to 56), all
of the 50- to 53-nt (+) SSDNAs may undergo productive strand transfer.
In contrast, the 69-nt DNA is a dead-end product which increased only
during the first 5 to 10 min of incubation, before the 80-nt transfer
product was detectable (Fig. 2); the explanation for this result is not
clear.
|
|
at
position 55. Hybridization with a plus-strand probe for sequences in
minus-strand U5 revealed a single fragment (data not shown), indicating
that the multiple bands detected with the minus-strand probe were not
the result of incomplete digestion with HindIII.
We conclude from these results that termination of (+) SSDNA synthesis
occurs at multiple sites in both the reconstituted and endogenous assay systems.
RNase H-catalyzed removal of tRNA3Lys from donor DNA. As illustrated in Fig. 1 (reaction 2), once the PBS has been reconstituted in plus-strand DNA, tRNA3Lys should be removed by the RNase H activity of RT. To verify the requirement for the RNase H step, we performed control experiments with RNase H-minus RT (62) (data not shown). We found that strand transfer did not occur with the mutant RT; however, the RNase H function could be supplied in trans by E. coli RNase H (data not shown; also see Fig. 7B).
To measure the time course of primer removal in our system (Fig. 5), the experimental conditions were the same as those used in Fig. 2, except that the 5' end of the tRNA moiety in the donor template was labeled with 32P and the 20-nt DNA primer was unlabeled. The RNA cleavage products were analyzed in a 6% sequencing gel, as described in Materials and Methods. The migrations of labeled, 76-nt tRNA3Lys and the labeled, 108-nt tRNA donor template are shown in Fig. 5, lanes tRNA and
RT,
respectively. Two classes of RNA cleavage products were observed: RNAs
of 73 to 75 nt and an RNA of 67 nt (Fig. 5A). The 75-nt RNA was
detectable on long exposures at 1 min (lane 1) and easily detectable by
3 min (lane 2), but the 73- and 74-nt RNAs were more visible at 5 min
(lanes 3); all of these bands decreased substantially by 15 to 20 min
(lanes 5 and 6). The 75-nt product results from the initial RNase H
cleavage at the 3' end of the tRNA, which leaves one base (an rA)
attached to the minus-strand donor template (23, 57, 66,
70). The appearance of the smaller 74- and 73-nt products may be
due to polymerase-independent cleavages of the 75-nt RNA. Further
cleavage of the initial RNA products would account for the production
of a 67-nt RNA; this product was detectable by 3 min (lane 2) but became more prominent during further incubation from 10 to 30 min
(lanes 4 to 8). Quantification of the data by PhosphorImager analysis
(Fig. 5B) demonstrated that virtually all of the 108-nt tRNA donor
template gave rise to a 67-nt RNA. The significant reduction in the
amount of the 75-nt product and almost complete disappearance of the
74- and 73-nt RNAs at later times during incubation indicate that the
73- to 75-nt RNAs are transient intermediates which are ultimately
converted to the final 67-nt RNA product.
|
Plus-strand transfer with an 18-nt RNA-DNA donor template. To investigate the question of whether secondary cleavage is required for plus-strand transfer, we realized that it would be necessary to use a simpler system, e.g., one in which the donor template has the 32-nt minus-strand DNA linked to an RNA oligonucleotide with the 18-nt sequence present at the 3' end of tRNA3Lys (Fig. 6), rather than to the entire tRNA, as shown in Fig. 1; all other reaction constituents were unchanged. To determine whether such a system would also mimic the events which occur during plus-strand transfer, we analyzed three reactions in parallel: plus-strand DNA synthesis (Fig. 6A), minus-strand elongation (Fig. 6B), and removal of the 18-nt RNA (Fig. 6C).
|
Requirement for secondary RNase H cleavage or NC activity for complete removal of tRNA3Lys. The results showing that secondary RNase H cleavage takes place in both the standard (Fig. 5) and modified (Fig. 6) systems suggested that the 17-nt RNA remaining after the initial cleavage, which is still hybridized to (+) SSDNA, must be shortened by 8 nt to completely remove the tRNA primer from minus-strand DNA and allow (+) SSDNA to anneal to the acceptor template. To investigate this possibility, we calculated the predicted Tm values for hybrids of different sizes using the MacVector program. Thus, the Tm values for 14- to 18-nt RNA-DNA hybrids with sequences from the 3' end of the tRNA are significantly greater than 37°C (ranging from 58 to 71°C); however, the values for 11- and 8-nt hybrids are 38 and 20°C, respectively. These data indicate that hybrids smaller than 11 nt will dissociate spontaneously during incubation at 37°C but that hybrids larger than 11 nt will not.
For a more direct test of a possible requirement for secondary RNase H cleavage in plus-strand transfer, we performed the experiment illustrated in Fig. 7. In this experiment, we modeled the step in which RNase H has already removed one base from the 18 nt at the 3' end of tRNA3Lys (Fig. 5) (see also references 23, 57, 66, and 70), leaving the minus-strand DNA donor with an rA at its 5' end and a 17-nt RNA (representing the 17 penultimate bases still attached to the rest of tRNA3Lys). Both the chimeric DNA-RNA oligonucleotide and the 17-nt RNA were hybridized to the 50-nt (+) SSDNA (see the schematic diagram in Fig. 7A). RNase H cleavage of the 17-nt RNA, labeled at its 5' end with 32P (Fig. 7B, lanes 1 to 4), and transfer of labeled (+) SSDNA (Fig. 7B, lanes 5 to 8) were examined in reactions with wild-type RT or RNase H-minus RT (62) with or without E. coli RNase H. The ability of NC to substitute for secondary RNase H cleavage was also determined (Fig. 7C).
|
Stimulation of the annealing step by HIV-1 NC. In view of the fact that NC can play a role in tRNA primer removal (see above and Fig. 7C) and is known to be a critical accessory protein for efficient HIV-1 minus-strand transfer (2, 15, 27, 41, 53, 60, 75), it was of interest to determine whether NC has other effects on plus-strand transfer. Initial experiments with the standard tRNA3Lys donor system (Fig. 1) indicated that NC stimulated synthesis of the plus-strand 80-nt transfer product by only 1.5- to 2-fold (data not shown). We therefore decided to investigate the influence of HIV-1 NC on individual steps which occur in the plus-strand transfer system (Fig. 1). When the experiments shown in Fig. 5A and 6C were repeated in the presence of NC, there was no significant effect on RNase H-catalyzed tRNA primer removal (data not shown). The data are also in accord with our earlier observation that NC has little effect on the rate and extent of degradation of the donor RNA template by RNase H (unpublished observation cited in reference 28) or on the nature of the RNase H cleavage pattern (28, 41) produced during minus-strand transfer.
To determine whether NC affects steps following primer removal, we used a partial system containing the 50-nt (+) SSDNA labeled with 32P and the acceptor DNA template but no donor DNA template or DNA oligonucleotide primer (Fig. 8). Reaction mixtures were incubated for various times up to 1 h, without NC or with three different NC concentrations: 0.14, 0.28, and 0.56 µM. [Since a 1:1 ratio of (+) SSDNA to acceptor was used, the numbers of nucleotides per NC molecule were 7, 3.5, and 1.75, respectively.]
|
| |
DISCUSSION |
|---|
|
|
|---|
The present study describes a reconstituted system which is designed to accurately reproduce the events associated with HIV-1 plus-strand transfer. Using this system, we were able to analyze in detail individual steps which contribute to the overall plus-strand transfer process. These include generation of (+) SSDNA, tRNA primer removal, annealing of (+) SSDNA and minus-strand acceptor DNA, and elongation of plus- and minus-strand DNA products. The goal of this work was to address several important questions. (i) Does termination of (+) SSDNA synthesis occur exclusively at the first modified base (a methyl A) at the 3' end of the tRNA primer? (ii) Does complete removal of the tRNA primer require secondary cleavage of bases at the 3' end of the tRNA? (iii) Does NC have a role in plus-strand transfer?
In the standard system, we used a 1:1 ratio of the donor and acceptor
templates to mimic the situation which exists during virus replication.
In addition, the donor DNA template consisted of the 5'-terminal
sequences of (
) SSDNA covalently attached to human
tRNA3Lys (Fig. 1). This template allowed us to
determine which bases in tRNA are termination sites for (+) SSDNA
synthesis. Our results demonstrate that these sites include the methyl
A at position 58 as well as two
bases at positions 55 and 39. Increasing the ratio of acceptor to donor or changing the
RT-to-template ratio did not lead to detectable changes in the pattern
of (+) SSDNA products or to any significant quantitative effect (data
not shown). The existence of multiple termination sites was also
observed in earlier studies with other reconstituted systems (4,
8). However, we have now shown that termination at the methyl A
and at (or near) the
at position 55 also occurs in reactions with detergent-treated HIV-1 virions (Fig. 4). This result indicates that
termination at multiple sites is not simply an in vitro artifact.
The use of multiple termination sites raises the question of whether
this phenomenon adversely affects plus-strand transfer (reviewed in
reference 68; see also reference
8). To examine this issue, we searched the database
for the genomic sequences of HIV-1 strains in the PBS region. We found
that for certain strains of HIV-1 in the consensus B class, including
NL4.3 (1) and MN (30) used in this study, and for
the ANT70 strain in the consensus O class, the three bases immediately
downstream of the PBS (5'-TTG) are complementary to the 3'-AAC bases at
positions 58 to 56, respectively, in the tRNA (42). In the
HIV-1 consensus U MAL strain there is a match between two of three base
pairs: the first two 5' bases downstream of the PBS are TT, but the 3' base is a T instead of a G (42). This means that for these
viruses, (+) SSDNA products which terminate after the methyl A, but
before the
at position 55, may be productively transferred (Fig.
3). Since RT is unable to copy modified bases (reference
49 and references therein), it appears likely that
termination of (+) SSDNA synthesis at sites beyond the methyl A is due
to incomplete modification of the tRNA in the host cell. Since the
degree of tRNA modification may vary depending on the source of the
tRNA, the extent to which multiple (+) SSDNA products are formed will also vary (e.g., compare results of Fig. 2 and 4, where the
tRNA3Lys primers are from human placenta and
HIV-1-infected H9 cells, respectively). It is of interest that in an
earlier study of hypomodification of tRNAs required for HIV ribosomal
frameshifting, it was reported that the chromatographic profiles of
tRNA3Lys in HIV-1-infected and uninfected H9 cells
differ (30a). It was suggested that this difference may
reflect hypomodification of bases in the anticodon loop of
tRNA3Lys from infected cells (30a), but
conceivably, other bases such as the methyl A at position 58 may be
undermodified as well. Another group has also observed that there are
multiple forms of tRNA3Lys in HIV-1 virions
(47a).
The annealing of (+) SSDNA to the minus-strand DNA acceptor is expected
to take place only if the tRNA primer is completely removed from the 5'
end of (
) SSDNA (reviewed in references 10 and
68). This idea is supported experimentally by the
finding that RNase H cleavage begins early in the incubation, i.e.,
between 1 and 3 min (Fig. 5A and 6C), while the 80-nt transfer product appears after a lag of 10 min (Fig. 2 and 6A and B). Furthermore, if
the tRNA removal step is bypassed, no lag phase is detected (Fig.
8A-1).
Since initial cleavage of only 1 base from the tRNA leaves a 17-nt RNA-DNA hybrid which has a high Tm, under these conditions, the tRNA is unable to completely dissociate from the complementary DNA bases in (+) SSDNA. To solve this problem, the virus must have a way to destabilize the remaining RNA-DNA hybrid. The appearance of a secondary cleavage product (67 nt [Fig. 5A] or 9 nt [Fig. 6C]) prior to detection of the 80-nt transfer product suggested that additional cleavage may be required for successful strand transfer. In the experiment illustrated in Fig. 7, we found that plus-strand transfer could occur when the polymerase-independent RNase H activity of RT (or RNase H activity provided in trans, e.g., by E. coli RNase H) could remove additional bases from the 3' end of the tRNA; with an RNase H-minus RT (62), plus-strand transfer was not detected (Fig. 7B). Apparently, in the absence of RNase H activity, RNA strand displacement by RT (19, 39) is not effective in this system. Interestingly, with avian myeloblastosis virus, the tRNATrp primer is removed intact by a single cleavage at the RNA-DNA junction (52), suggesting that, in this case, RNA strand displacement and/or NC (see below) may play a role in primer removal.
In a report by Cameron et al. (9), it was shown that an HIV-1 RT mutant having a deletion of the 13 C-terminal residues from the p51 subunit and lacking the ability to catalyze polymerase-independent RNase H cleavage could not support efficient minus-strand transfer in vitro. However, when the 71-amino-acid form (NC71) (but not the 55-amino-acid form) of HIV-1 NC was added, the defect in strand transfer was suppressed (9). This observation was interpreted as evidence for the formation of a specific complex between RT and the C-terminal residues in NC71 (9).
In this work on HIV-1 plus-strand transfer, we find that addition of HIV-1 NC (having 55 amino acids [31]) and the E478Q RNase H-minus RT (62) to a reaction mixture in which the initial cleavage has already occurred (Fig. 7A) results in production of the 80-nt strand transfer product; this effect is dependent on the concentration of NC (Fig. 7C). While our data do not address the question of whether an NC-RT complex is involved in this phenomenon, it seems plausible that the nucleic acid chaperone activity of NC (32, 59) is responsible for destabilization of the RNA-DNA hybrid remaining after the initial cleavage event.
How might this occur? One can view the annealing of (+) SSDNA to the 18-nt sequence at the 3' end of the tRNA and to the minus-strand PBS sequence in the acceptor DNA template as a strand exchange reaction. NC establishes an equilibrium between these two hybrids. However, the presence of (+) SSDNA in the DNA duplex (rather than the RNA-DNA hybrid) is ultimately favored: both strands of the duplex can be elongated by the polymerase activity of RT, and this elongation leads to formation of a structure with a greater number of base pairs and greater thermodynamic stability than in the RNA-DNA hybrid. Thus, as more of the (+) SSDNA is annealed to the acceptor, less (+) SSDNA is available to hybridize to the tRNA and the tRNA will eventually be released. (Note that, according to these considerations, NC does not need to have a direct effect on RNase H cleavage and that in fact, as mentioned above, it does not have such an effect [data not shown].) This situation resembles the NC-catalyzed strand exchange reaction described in the experiments of Tsuchihashi and Brown (69), which showed that annealing of DNA strands with a large number of complementary base pairs was favored over annealing to DNA strands with a smaller number of base-paired regions. It is also possible that in our experiment, there may be a small contribution to primer removal by NC-stimulated RNA strand displacement activity (4, 39).
The finding that NC can substitute for secondary cleavage at the 3' end of the tRNA raises another issue: does NC facilitate primer removal when wild-type RT is available? In the experiment illustrated in Fig. 7, we found that when wild-type RT was used instead of the mutant version, addition of NC stimulated synthesis of the 80-nt DNA by two- to threefold (Fig. 7C). These observations suggest that during normal HIV-1 replication, both polymerase-independent RNase H cleavage and NC activity can contribute to removal of the primer and formation of the DNA duplex between (+) SSDNA and the minus-strand acceptor DNA template.
Although NC has been shown to promote DNA extension with a long DNA template (37), in our system, elongation of a relatively small number of bases (30 nt) after synthesis of (+) SSDNA is not affected by NC (data not shown). This is presumably due to the fact that the sequence being extended does not have secondary structures which could interfere with RT movement along the DNA template.
What we do observe is a large stimulatory effect of NC on the annealing of the complementary PBS sequences in (+) SSDNA and the minus-strand DNA acceptor template (Fig. 8). Several studies have shown that NC stimulates DNA duplex formation with non-PBS-containing reactants (14, 16, 44, 46, 69), but to our knowledge, this effect of NC on DNA annealing has not been previously demonstrated with DNA molecules representing the actual intermediates in plus-strand transfer. The data of Fig. 8 show that RT also facilitates annealing; however, in the presence of a high concentration of NC, the contribution of RT is less significant.
Semilogarithmic plots of the kinetics of annealing plus elongation and
of annealing only show curvature (Fig. 8A-2 and B-2) and are consistent
with the possibility that the annealing reaction follows second-order
kinetics, as is typical for hybridization reactions (reference
16 and references therein). In minus-strand transfer, however, annealing of the R regions in (
) SSDNA and the 3'
acceptor RNA template follows pseudo first-order kinetics and is
independent of nucleic acid concentration (75). Since approximately two-thirds of R consists of the stable, 59-nt TAR stem-loop, it has been proposed that an unfolding step is rate limiting
(75). The apparent difference between the annealing reactions in plus- and minus-strand transfer may reflect the fact that
the 18-nt PBS sequence is smaller and much less structured than the TAR
sequence in R, thereby precluding the requirement for a rate-limiting,
unfolding step (75). Rather, with PBS annealing, it is more
likely that formation of the DNA duplex is a bimolecular reaction, with
rate-limiting nucleation followed by fast zippering (16).
Our results (Fig. 8B-1) demonstrate that the stimulatory effect of NC on annealing is concentration dependent. Under the conditions of our experiment, there is already a significant effect when NC is added at a ratio of 7 nt to 1 NC molecule (0.14 µM); this amount of NC corresponds to the estimated ratio of RNA nucleotides to NC molecules in the HIV-1 particle (31) and also to the size of the binding site calculated from in vitro experiments (16, 38, 74). An increase in NC concentration to as high a ratio as 1.75 nt to 1 NC molecule (0.56 µM) leads to an even greater increase in the rate of annealing, i.e., ~20-fold greater than the rate achieved in the absence of NC (Fig. 8B-2).
In summary, we have modeled the events associated with HIV-1
plus-strand transfer and have defined the individual steps in molecular
terms. We find that in two respects, the strategy employed by the virus
for plus-strand transfer strikingly parallels that used for
minus-strand transfer. (i) Removal of the tRNA primer or degradation of
the RNA donor template, respectively, is required, and in both cases,
there must be destabilization of a terminal RNA-DNA hybrid by the
polymerase-independent RNase H activity of RT and/or by the action of
NC. (ii) Annealing of complementary bases (PBS or R sequences) in the
initial copy of the donor template [i.e., (+) or (
) SSDNA,
respectively] with the acceptor molecule is required for the actual
strand transfer event. Moreover, NC functioning as a nucleic acid
chaperone has a profound stimulatory effect on each of these annealing reactions.
| |
ACKNOWLEDGMENTS |
|---|
We thank Stuart Le Grice for his generous gift of an RNase H-minus mutant RT, Robert Crouch for kindly supplying E. coli RNase H, and Bradley Kane for graciously providing HIV-1 NC protein. We are also indebted to Robert Crouch, Stephen Hughes, and Michael Powell for valuable suggestions concerning the experiment described in Fig. 7 and to Alan Rein for a thoughtful reading of the manuscript.
This work was supported in part by the National Institutes of Health Intramural AIDS Targeted Antiviral Program and in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract NO1-CO-56000.
| |
ADDENDUM IN PROOF |
|---|
After this work was accepted for publication, we became aware of a report (S. Auxilien, G. Keith, S. F. J. Le Grice, and J.-L. Darlix, J. Biol. Chem. 274:4412-4420, 1999) describing the relationship between multiple termination sites for (+) SSDNA synthesis and the fidelity of HIV-1 plus-strand DNA transfer.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Laboratory of Molecular Genetics, NICHD, Building 6B, Room 216, NIH, Bethesda, MD 20892. Phone: (301) 496-1970. Fax: (301) 496-0243. E-mail: judith_levin{at}nih.gov.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Adachi, A.,
H. E. Gendelman,
S. Koenig,
T. Folks,
R. Willey,
A. Rabson, and M. A. Martin.
1986.
Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
J. Virol.
59:284-291 |
| 2. | Allain, B., M. Lapadat-Tapolsky, C. Berlioz, and J.-L. Darlix. 1994. Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. EMBO J. 13:973-981[Medline]. |
| 3. | Arts, E. J., and M. A. Wainberg. 1996. Human immunodeficiency virus type 1 reverse transcriptase and early events in reverse transcription. Adv. Virus Res. 46:97-163[Medline]. |
| 4. | Ben-Artzi, H., J. Shemesh, E. Zeelon, B. Amit, L. Kleiman, M. Gorecki, and A. Panet. 1996. Molecular analysis of the second template switch during reverse transcription of the HIV RNA template. Biochemistry 35:10549-10557[Medline]. |
| 5. |
Ben-Artzi, H.,
E. Zeelon,
B. Amit,
A. Wortzel,
M. Gorecki, and A. Panet.
1993.
RNase H activity of reverse transcriptases on substrates derived from the 5' end of retroviral genome.
J. Biol. Chem.
268:16465-16471 |
| 6. | Bertrand, E. L., and J. J. Rossi. 1994. Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1. EMBO J. 13:2904-2912[Medline]. |
| 7. |
Boone, L. R., and A. M. Skalka.
1981.
Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. II. Evidence for a strand displacement mechanism in plus-strand synthesis.
J. Virol.
37:117-126 |
| 8. |
Burnett, B. P., and C. S. McHenry.
1997.
Posttranscriptional modification of retroviral primers is required for late stages of DNA replication.
Proc. Natl. Acad. Sci. USA
94:7210-7215 |
| 9. |
Cameron, C. E.,
M. Ghosh,
S. F. J. Le Grice, and S. J. Benkovic.
1997.
Mutations in HIV reverse transcriptase which alter RNase H activity and decrease strand transfer efficiency are suppressed by HIV nucleocapsid protein.
Proc. Natl. Acad. Sci. USA
94:6700-6705 |
| 10. | Champoux, J. J. 1993. Roles of ribonuclease H in reverse transcription, p. 103-117. In A. M. Skalka, and S. P. Goff (ed.), Reverse transcriptase. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 11. | Cirino, N. M., C. E. Cameron, J. S. Smith, J. W. Rausch, M. J. Roth, S. J. Benkovic, and S. F. J. Le Grice. 1995. Divalent cation modulation of the ribonuclease functions of human immunodeficiency virus reverse transcriptase. Biochemistry 34:9936-9943[Medline]. |
| 12. | Coffin, J. M., S. H. Hughes, and H. E. Varmus. 1997. Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 13. | Darlix, J.-L., M. Lapadat-Tapolsky, H. de Rocquigny, and B. P. Roques. 1995. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 254:523-537[Medline]. |
| 14. | Davis, W. R., S. Gabbara, D. Hupe, and J. A. Peliska. 1998. Actinomycin D inhibition of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase and nucleocapsid protein. Biochemistry 37:14213-14221[Medline]. |
| 15. | DeStefano, J. J. 1995. Human immunodeficiency virus nucleocapsid protein stimulates strand transfer from internal regions of heteropolymeric RNA templates. Arch. Virol. 140:1775-1789[Medline]. |
| 16. | Dib-Hajj, F., R. Khan, and D. P. Giedroc. 1993. Retroviral nucleocapsid proteins possess potent nucleic acid strand renaturation activity. Protein Sci. 2:231-243[Medline]. |
| 17. |
Feng, Y.-X.,
T. D. Copeland,
L. E. Henderson,
R. J. Gorelick,
W. J. Bosche,
J. G. Levin, and A. Rein.
1996.
HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro.
Proc. Natl. Acad. Sci. USA
93:7577-7581 |
| 18. |
Fu, T.-B., and J. Taylor.
1992.
When retroviral reverse transcriptases reach the end of their RNA templates.
J. Virol.
66:4271-4278 |
| 19. |
Fuentes, G. M.,
P. J. Fay, and R. A. Bambara.
1996.
Relationship between plus strand DNA synthesis and removal of downstream segments of RNA by human immunodeficiency virus, murine leukemia virus and avian myeloblastoma virus reverse transcriptases.
Nucleic Acids Res.
24:1719-1726 |
| 20. |
Fuentes, G. M.,
C. Palaniappan,
P. J. Fay, and R. A. Bambara.
1996.
Strand displacement synthesis of the central polypurine tract region of HIV-1 promotes DNA to DNA strand transfer recombination.
J. Biol. Chem.
271:29605-29611 |
| 21. |
Fuentes, G. M.,
L. Rodríguez-Rodríguez,
P. J. Fay, and R. A. Bambara.
1995.
Use of an oligoribonucleotide containing the polypurine tract as a primer by HIV reverse transcriptase.
J. Biol. Chem.
270:28169-28176 |
| 22. |
Furfine, E. S., and J. E. Reardon.
1991.
Reverse transcriptase · RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities.
J. Biol. Chem.
266:406-412 |
| 23. | Furfine, E. S., and J. E. Reardon. 1991. Human immunodeficiency virus reverse transcriptase ribonuclease H: specificity of tRNALys3-primer excision. Biochemistry 30:7041-7046[Medline]. |
| 24. | Gao, H.-Q., P. L. Boyer, E. Arnold, and S. H. Hughes. 1998. Effects of mutations in the polymerase domain on the polymerase, RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase. J. Mol. Biol. 277:559-572[Medline]. |
| 25. | Gilboa, E., S. W. Mitra, S. Goff, and D. Baltimore. 1979. A detailed model of reverse transcription and tests of crucial aspects. Cell 18:93-100[Medline]. |
| 26. |
Gopalakrishnan, V.,
J. A. Peliska, and S. J. Benkovic.
1992.
Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities.
Proc. Natl. Acad. Sci. USA
89:10763-10767 |
| 27. | Guo, J., L. E. Henderson, J. Bess, B. Kane, and J. G. Levin. 1997. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA. J. Virol. 71:5178-5188[Abstract]. |
| 28. |
Guo, J.,
T. Wu,
J. Bess,
L. E. Henderson, and J. G. Levin.
1998.
Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays.
J. Virol.
72:6716-6724 |
| 29. | Guo, J., W. Wu, Z. Y. Yuan, K. Post, R. J. Crouch, and J. G. Levin. 1995. Defects in primer-template binding, processive DNA synthesis, and RNase H activity associated with chimeric reverse transcriptases having the murine leukemia virus polymerase domain joined to Escherichia coli RNase H. Biochemistry 34:5018-5029[Medline]. |
| 30. | Gurgo, C., H.-G. Guo, G. Franchini, A. Aldovini, E. Collalti, K. Farrell, F. Wong-Staal, R. C. Gallo, and M. S. Reitz, Jr. 1988. Envelope sequences of two new United States HIV-1 isolates. Virology 164:531-536[Medline]. |
| 30a. | Hatfield, D., Y.-X. Feng, B. J. Lee, A. Rein, J. G. Levin, and S. Oroszlan. 1989. Chromatographic analysis of the aminoacyl-tRNAs which are required for translation of codons at and around the ribosomal frameshift sites of HIV, HTLV-1, and BLV. Virology 173:736-742[Medline]. |
| 31. |
Henderson, L. E.,
M. A. Bowers,
R. C. Sowder II,
S. A. Serabyn,
D. G. Johnson,
J. W. Bess, Jr.,
L. O. Arthur,
D. K. Bryant, and C. Fenselau.
1992.
Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences.
J. Virol.
66:1856-1865 |
| 32. |
Herschlag, D.
1995.
RNA chaperones and the RNA folding problem.
J. Biol. Chem.
270:20871-20874 |
| 33. | Herschlag, D., M. Khosla, Z. Tsuchihashi, and R. L. Karpel. 1994. An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis. EMBO J. 13:2913-2924[Medline]. |
| 34. |
Hong, T.,
K. Drlica,
A. Pinter, and E. Murphy.
1991.
Circular DNA of human immunodeficiency virus: analysis of circle junction nucleotide sequences.
J. Virol.
65:551-555 |
| 35. |
Hottiger, M.,
V. N. Podust,
R. L. Thimmig,
C. McHenry, and U. Hübscher.
1994.
Strand displacement activity of the human immunodeficiency virus type 1 reverse transcriptase heterodimer and its individual subunits.
J. Biol. Chem.
269:986-991 |
| 36. |
Huber, H. E.,
J. M. McCoy,
J. S. Seehra, and C. C. Richardson.
1989.
Human immunodeficiency virus 1 reverse transcriptase. Template binding, processivity, strand displacement synthesis, and template switching.
J. Biol. Chem.
264:4669-4678 |
| 37. | Ji, X., G. J. Klarmann, and B. D. Preston. 1996. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro. Biochemistry 35:132-143[Medline]. |
| 38. |
Karpel, R. L.,
L. E. Henderson, and S. Oroszlan.
1987.
Interactions of retroviral structural proteins with single-stranded nucleic acids.
J. Biol. Chem.
262:4961-4967 |
| 39. |
Kelleher, C. D., and J. J. Champoux.
1998.
Characterization of RNA strand displacement synthesis by Moloney murine leukemia virus reverse transcriptase.
J. Biol. Chem.
273:9976-9986 |
| 40. |
Khan, R., and D. P. Giedroc.
1992.
Recombinant human immunodeficiency virus type 1 nucleocapsid (NCp7) protein unwinds tRNA.
J. Biol. Chem.
267:6689-6695 |
| 41. |
Kim, J. K.,
C. Palaniappan,
W. Wu,
P. J. Fay, and R. A. Bambara.
1997.
Evidence for a unique mechanism of strand transfer from the transactivation response region of HIV-1.
J. Biol. Chem.
272:16769-16777 |
| 42. | Korber, B., B. Foley, T. Leitner, F. McCutchan, B. Hahn, J. W. Mellors, G. Myers, and C. Kuiken (ed.). 1997. Human retroviruses and AIDS. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N.M. |
| 43. | Kulkosky, J., R. A. Katz, and A. M. Skalka. 1990. Terminal nucleotides of the preintegrative linear form of HIV-1 DNA deduced from the sequence of circular DNA junctions. J. Acquired Immune Defic. Syndr. 3:852-858. |
| 44. |
Lapadat-Tapolsky, M.,
H. De Rocquigny,
D. Van Gent,
B. Roques,
R. Plasterk, and J.-L. Darlix.
1993.
Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle.
Nucleic Acids Res.
21:831-839 |
| 45. | Lapadat-Tapolsky, M., C. Gabus, M. Rau, and J.-L. Darlix. 1997. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. J. Mol. Biol. 268:250-260[Medline]. |
| 46. |
Lapadat-Tapolsky, M.,
C. Pernelle,
C. Borie, and J.-L. Darlix.
1995.
Analysis of the nucleic acid annealing activities of nucleocapsid protein from HIV-1.
Nucleic Acids Res.
23:2434-2441 |
| 47. |
Li, X.,
Y. Quan,
E. J. Arts,
Z. Li,
B. D. Preston,
H. De Rocquigny,
B. P. Roques,
J.-L. Darlix,
L. Kleiman,
M. A. Parniak, and M. A. Wainberg.
1996.
Human immunodeficiency virus type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA3Lys in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site.
J. Virol.
70:4996-5004 |
| 47a. | Li, Z., A. Shalom, Y. Huang, J. Mak, E. Arts, M. A. Wainberg, and L. Kleiman. 1996. Multiple forms of tRNALys3 in HIV-1. Biochem. Biophys. Res. Commun. 227:530-540[Medline]. |
| 48. | Litvak, S., L. Sarih-Cottin, M. Fournier, M. Andreola, and L. Tarrago-Litvak. 1994. Priming of HIV replication by tRNALys3: role of reverse transcriptase. Trends Biochem. Sci. 19:114-118[Medline]. |
| 49. | Marquet, R. 1998. Importance of modified nucleotides in replication of retroviruses, plant pararetroviruses, and retrotransposons, p. 517-533. In H. Grosjean, and R. Benne (ed.), Modification and editing of RNA. ASM Press, Washington, D.C. |
| 50. | Miller, M. D., C. M. Farnet, and F. D. Bushman. 1997. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71:5382-5390[Abstract]. |
| 51. | Müller, G., B. Strack, J. Dannull, B. S. Sproat, A. Surovoy, G. Jung, and K. Moelling. 1994. Amino acid requirements of the nucleocapsid protein of HIV-1 for increasing catalytic activity of a Ki-ras ribozyme in vitro. J. Mol. Biol. 242:422-429[Medline]. |
| 52. | Omer, A. C., and A. J. Faras. 1982. Mechanism of release of the avian retrovirus tRNATrp primer molecule from viral DNA by ribonuclease H during reverse transcription. Cell 30:797-805[Medline]. |
| 53. | Peliska, J. A., S. Balasubramanian, D. P. Giedroc, and S. J. Benkovic. 1994. Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity. Biochemistry 33:13817-13823[Medline]. |
| 54. |
Peliska, J. A., and S. J. Benkovic.
1992.
Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase.
Science
258:1112-1118 |
| 55. | Post, K., J. Guo, E. Kalman, T. Uchida, R. J. Crouch, and J. G. Levin. 1993. A large deletion in the connection subdomain of murine leukemia virus reverse transcriptase or replacement of the RNase H domain with Escherichia coli RNase H results in altered polymerase and RNase H activities. Biochemistry 32:5508-5517[Medline]. |
| 56. |
Powell, M. D., and J. G. Levin.
1996.
Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immunodeficiency virus type 1 polypurine tract.
J. Virol.
70:5288-5296 |
| 57. |
Pullen, K. A.,
L. K. Ishimoto, and J. J. Champoux.
1992.
Incomplete removal of the RNA primer for minus-strand DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.
J. Virol.
66:367-373 |
| 58. |
Randolph, C. A., and J. J. Champoux.
1994.
The use of DNA and RNA oligonucleotides in hybrid structures with longer polynucleotide chains to probe the structural requirements for Moloney murine leukemia virus plus-strand priming.
J. Biol. Chem.
269:19207-19215 |
| 59. | Rein, A., L. E. Henderson, and J. G. Levin. 1998. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem. Sci. 23:297-301[Medline]. |
| 60. |
Rodríguez-Rodríguez, L.,
Z. Tsuchihashi,
G. M. Fuentes,
R. A. Bambara, and P. J. Fay.
1995.
Influence of human immunodeficiency virus nucleocapsid protein on synthesis and strand transfer by the reverse transcriptase in vitro.
J. Biol. Chem.
270:15005-15011 |
| 61. | Roth, M. J., P. L. Schwartzberg, and S. P. Goff. 1989. Structure of the termini of DNA intermediates in the integration of retroviral DNA: dependence on IN function and terminal DNA sequence. Cell 58:47-54[Medline]. |
| 62. | Schatz, O., F. V. Cromme, F. Grüninger-Leitch, and S. F. J. Le Grice. 1989. Point mutations in conserved amino acid residues within the C-terminal domain of HIV-1 reverse transcriptase specifically repress RNase H function. FEBS Lett. 257:311-314[Medline]. |
| 63. |
Schultz, S. J.,
S. H. Whiting, and J. J. Champoux.
1995.
Cleavage specificities of Moloney murine leukemia virus RNase H implicated in the second strand transfer during reverse transcription.
J. Biol. Chem.
270:24135-24145 |
| 64. | Smith, C. M., W. B. Potts III, J. S. Smith, and M. J. Roth. 1997. RNase H cleavage of tRNAPro mediated by M-MuLV and HIV-1 reverse transcriptases. Virology 229:437-446[Medline]. |
| 65. |
Smith, J. S.,
S. Kim, and M. J. Roth.
1990.
Analysis of long terminal repeat circle junctions of human immunodeficiency virus type 1.
J. Virol.
64:6286-6290 |
| 66. |
Smith, J. S., and M. J. Roth.
1992.
Specificity of human immunodeficiency virus-1 reverse transcriptase-associated ribonuclease H in removal of the minus-strand primer, tRNALys3.
J. Biol. Chem.
267:15071-15079 |
| 67. |
Tanchou, V.,
D. Decimo,
C. Péchoux,
D. Lener,
V. Rogemond,
L. Berthoux,
M. Ottmann, and J.-L. Darlix.
1998.
Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication.
J. Virol.
72:4442-4447 |
| 68. | Telesnitsky, A., and S. P. Goff. 1993. Strong-stop strand transfer during reverse transcription, p. 49-83. In A. M. Skalka, and S. P. Goff (ed.), Reverse transcriptase. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 69. |
Tsuchihashi, Z., and P. O. Brown.
1994.
DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein.
J. Virol.
68:5863-5870 |
| 70. |
Whitcomb, J. M.,
R. Kumar, and S. H. Hughes.
1990.
Sequence of the circle junction of human immunodeficiency virus type 1: implications for reverse transcription and integration.
J. Virol.
64:4903-4906 |
| 71. |
Whiting, S. H., and J. J. Champoux.
1994.
Strand displacement synthesis capability of Moloney murine leukemia virus reverse transcriptase.
J. Virol.
68:4747-4758 |
| 72. | Whiting, S. H., and J. J. Champoux. 1998. Properties of strand displacement synthesis by Moloney murine leukemia virus reverse transcriptase: mechanistic implications. J. Mol. Biol. 278:559-577[Medline]. |
| 73. |
Wu, W.,
L. E. Henderson,
T. D. Copeland,
R. J. Gorelick,
W. J. Bosche,
A. Rein, and J. G. Levin.
1996.
Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract.
J. Virol.
70:7132-7142 |
| 74. |
You, J. C., and C. S. McHenry.
1993.
HIV nucleocapsid protein. Expression in Escherichia coli, purification, and characterization.
J. Biol. Chem.
268:16519-16527 |
| 75. |
You, J. C., and C. S. McHenry.
1994.
Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription.
J. Biol. Chem.
269:31491-31495 |
| 76. | Yusupova, G., J.-M. Lanchy, M. Yusupov, G. Keith, S. F. J. Le Grice, C. Ehresmann, B. Ehresmann, and R. Marquet. 1996. Primer selection by HIV-1 reverse transcriptase on RNA-tRNA3Lys and DNA-tRNA3Lys hybrids. J. Mol. Biol. 261:315-321[Medline]. |
| 77. |
Zhan, X., and R. J. Crouch.
1997.
The isolated RNase H domain of murine leukemia virus reverse transcriptase. Retention of activity with concomitant loss of specificity.
J. Biol. Chem.
272:22023-22029 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»